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A total of 3,101 fecal specimens were collected during
an 8-year survey for rotavirus infection in São Paulo, Brazil.
Group A rotavirus was detected in 774 (25.0%) specimens.
Of these, 431 strains (55.7%) were analyzed for G and P
types by reverse transcription–polymerase chain reaction;
G1 was the predominant serotype (68.2%), followed by G9
(17.2%), G4 (6.3%), G2 (1.2%), G3 (0.7%), mixed infection
(1.8%), and untypeable (4.6%). Both rotavirus G and P
types could be established in 332 strains (77.0%). We iden-
tified the 4 most common strains worldwide: P[8]G1
(66.6%), P[4]G2 (1.0%), P[8]G3 (0.6%), and P[8]G4
(7.2%). Among the single G9 strains detected, VP4 geno-
typing showed that P[8]G9 was the most prevalent, fol-
lowed by P[4]G9 and P[6]G9. The emergence and high
frequency of rotavirus G9 in São Paulo, Brazil, and other
parts of the world will affect the development and evalua-
tion of future vaccines.
G
roup A rotavirus is the most common cause of acute
gastroenteritis in infants and young children world-
wide (1). More than 130 million cases of diarrhea each
year are attributed to rotavirus. It is estimated to cause
>400,000 deaths annually in children <5 years of age and
is responsible for 2 million hospital admissions due to
acute diarrhea worldwide. In developing countries, an esti-
mated 1,205 children die from rotavirus disease each day,
and 82% of these deaths occur in children in the poorest
countries (2)
Rotavirus serotypes are determined by neutralizing
antibody responses to each of the 2 outer capsids proteins,
VP7 (G serotype) and VP4 (P serotype) (1). To date, 11
VP7 G serotypes and 13 P serotypes have been identified
in humans. Serotypes G1, G2, G3, and G4 are frequently
associated with diarrhea in humans and have become
prime targets for vaccine development (3,4). The recent
emergence and wide distribution of rotavirus G9 indicate
that this serotype may become the fifth relevant strain
(5,6). Unusual types of rotavirus have been described in
certain settings. The G5 type has been reported in Brazil,
Argentina, Paraguay, Cameroon, and the United Kingdom
(6,7); G6 has been detected in Italy, Australia, India, the
United States, Belgium, and Hungary; G8 has been fre-
quently isolated in Africa and sporadically in other coun-
tries; rotavirus G10 specificity has been reported in the
United Kingdom, India, Thailand, Paraguay, and Brazil
(6); G11 type was recently detected in Dhaka, Bangladesh
(4); and the G12 type has been detected in the Philippines
(8), Thailand (9), the United States (10), India (11), Japan
(12), Korea (13), Argentina (14), and Brazil (15).
The genotypes VP4 P[8] and P[4] are the most common
Ptypes that infect humans. The P[8] type is generally asso-
ciated with VP7 types G1, G3, and G4, and the P[4] type
is associated with G2 (16). Combined G and P genotyping
may have advantages in identifying reassortants as unusu-
al or new virus strains (17). Continued surveillance of the
diverse rotavirus strains circulating in a community is cru-
cial before developing a vaccine and during and after
implementing an immunization program. Therefore, we
describe the results of an 8-year surveillance study of G-
and P-type rotavirus strains from persons with acute diar-
rhea in the state of São Paulo, Brazil.
Materials and Methods
From 1996 to 2003, a total of 3,101 fecal specimens
were collected from children <5 years of age, school-age
children (5–17 years), adults (18–59 years), and elderly
patients (>60 years) with acute gastroenteritis. These
patients received treatment for diarrhea at the departments
of public health or were admitted to hospitals in several
cities in São Paulo State, in southeast Brazil. São Paulo
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Paulo, São Paulo, BrazilState has an area of ≈248,800 km2 and a population of 40
million (21.5% of the population of Brazil). Figure 1
shows main cities in São Paulo where samples were col-
lected. Epidemiologic data (age, date of diarrhea onset,
date of sample collection) were available from some
patients. Specimens were stored at –20°C until tested for
rotavirus and characterized. Study methods were approved
by the ethical committee of Adolfo Lutz Institute.
All specimens were screened for rotavirus by using a
commercial enzyme-linked immunosorbent assay
(ELISA) (Premier Rotaclone, Meridian Diagnostics,
Cincinnati, OH, USA) with monoclonal antibodies specif-
ic for group A human rotavirus, according to the manufac-
turer’s protocol. Rotavirus double-stranded RNA(dsRNA)
was extracted directly from stool by the TRIzol method
(Invitrogen, Carlsbad, CA, USA) and precipitated with
isopropanol. The extracted dsRNAwas subjected to G and
P typing by multiplex reverse transcription–polymerase
chain reaction (RT-PCR) with type-specific primers.
Consensus primers Beg9 and End9 were used in a first-
round PCR (30 cycles) to amplify the full-length VP7 gene
(1,062 bp); cDNA was used in a second-round PCR for G
typing (25 cycles) with primer set aBT1 (G1), aCT2 (G2),
aET3 (G3), aDT4 (G4), aFT9 (G9) and primer set FT5
(G5), DT6 (G6), HT8 (G8), ET10 (G10), BT11 (G11)
(18,19). For P typing, consensus primers Con2 and Con3
were used in a first-round RT-PCR (30 cycles) to amplify
the 876 bp of the VP8* region of the VP4 gene, and the
second-round PCR (20 cycles) used primer set 1T-1 (P[8]),
2T-1 (P[4]), 3T-1 (P[6]), 4T-1 (P[9]), 5T-1 (P[10]) (20). All
PCR products were analyzed by electrophoresis in 1.2%
agarose gels, containing 0.5 µg ethidium bromide per mil-
liliter and visualized under UV illumination.
Results
Rotavirus was detected in 774 (25.0%) of 3,101 speci-
mens collected from children, adults, and elderly patients
in São Paulo during an 8-year period. Rotavirus infection
was found predominantly in the winter and in drier
months. The incidence peaked in August (Figure 2). The
age or date of birth was provided for 677 (87.5%) of 774
patients who tested positive for rotavirus. Rotavirus dis-
ease was detected mainly in children <2 years of age (463
[59.8%] of 774), and peaks of incidence occurred from 7
to 12 months (Figure 3). However, rotavirus infection also
was detected in adults and elderly patients (55 [7.1%] of
774).
We randomly selected 431 rotavirus-positive samples
(55.7%) for determination of G and P genotypes by an RT-
PCR assay. G1 was the predominant serotype in these sam-
ples (294, 68.2%), followed by G9 (74, 17.2%), G4 (27,
6.3%), G2 (5, 1.2%), G3 (3, 0.7%), mixed infection (8,
1.8%), and untypeable (20, 4.6%) (Table 1). The distribu-
tion of rotavirus types in São Paulo during this 8-year peri-
od shows that G1 was the most prevalent genotype in most
years, but it was displaced by G9 in 2002. Incidence of G2
and G3 serotypes was low during the period of analysis.
Frequency of G4 serotype differed during the surveillance
period; it was not detected in 1996 and 2003. We found
several mixed infections from 2000 to 2003 (G1+G4,
G1+G9, G2+G3, and G4+G9).
Both rotavirus G and P types could be established in
332 (77.0%) strains, and 17 different P and G associations
were detected (Table 2). Of these, we identified the 4 most
globally common strains, P[8]G1, P[8]G4, P[4]G2, and
P[8]G3, which represented 75.3% of all typed rotavirus
strains. Uncommon strains were also detected, including
P[8]G9, P[4]G9, P[6]G9, P[4]G1, P[6]G1, P[6]G2, and
P[4]G4. And combination P-G mixed infections were as
diverse as P[8]G1+G4, P[8]G1+G9, P[6]G1+G9,
P[4]G2+G3, and P[8]G4+G9.
Discussion
We detected rotaviruses in the specimens of 25.0% of
patients with acute diarrhea, which is comparable to the
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Figure 1. Map of São Paulo State, Brazil, indicating where fecal
specimens were collected during the 8-year survey period.prevalence seen in other studies in Brazil (21). Among
children <5 years of age, we detected rotavirus infection
mainly in those <2 years of age (81.0%) (data not shown);
in adults, rotavirus was detected less frequently (7.1%).
The finding of a low percentage of rotavirus infection
among adults is likely because the disease is generally per-
ceived to be a childhood infection (22). Common epidemi-
ologic settings for rotavirus infection among adults include
endemic disease, epidemic outbreak, travel-related infec-
tion, and child-to-adult transmission (23).
In studies performed at various locations in Brazil with
diverse climatic conditions, rotavirus disease appears to
occur year-round (24). In São Paulo State, however, infec-
tion occurred mainly during cooler and drier seasons; sim-
ilar observations have been made in other countries with
temperate climates (16).
During the 8-year period studied, the G1 type was the
most prevalent rotavirus strain. The second most prevalent
was the G9 type, which accounted for 17.2% of disease,
followed by G4, G2, and G3, which are common around
the world. G1 was the most prevalent type in most years;
however, it was displaced by G9 during the 2002 season,
when G9 accounted for 46.9% of typed isolates. The G9
type has been reported to be a common cause of diarrhea
and has become the fifth most common serotype, which
suggests that it may be a substantial cause of diarrhea in
humans (5,6). This type has been detected in Brazil since
1997 (25,26).
Surveillance on rotavirus types has been performed in
São Paulo for >18 years, from 1986 to 2003 (27,28). The
first G9 type was isolated in 2000 and has been fluctuating
in frequency since its emergence (Table 1). The G5 type,
normally associated with animal rotavirus (pigs and hors-
es), has been frequently detected in persons in Brazil and
it was considered an endemic virus (28,29). Nevertheless,
in our survey in São Paulo, G5 rotavirus was not detected.
Its incidence in Brazil has been decreasing over the last
few years, and it may be disappearing (25,26); this type of
rotavirus is likely to be a cyclic form. G9 strains have also
been detected in animals (lambs and pigs [1]); detection of
animal rotavirus provides evidence for natural human-ani-
mal genetic reassortment (30). Surveillance programs for
animal rotavirus may aid in the development of next-gen-
eration vaccines (6).
Characterization of rotavirus VP4 types showed various
strains. In this study, the 4 most globally common strains,
P[8]G1, P[4]G2, P[8]G3, and P[8]G4, represented 75.3%
of all typed viruses. The most prevalent association was
P[8]G1, followed by P[8]G9. Worldwide, the 4 predomi-
nant rotavirus genotypes make up nearly 90% of all
rotavirus infections (16). In Brazil, epidemiologic data on
the prevalence of G and P types have been collected since
the 1980s (27). This study showed great diversity of
rotavirus strains in São Paulo. The uncommon genotypes
P[4]G1, P[4]G4, P[4]+P[6]G1, and P[6]+P[8]G1 were also
seen in some cases, similar to results from other countries
(31,32). In our study, the uncommon genotypes P[6]G1,
P[6]G2, and P[6]G9 were detected in children with acute
diarrhea with an average age of 14 months (data not
shown). Many studies have shown that this type is often
detected in very young children with diarrhea, which sug-
gests that P[6] strains may promote infection at an early
age. Originally, P[6] in association with rotavirus types
G1–G4 was detected in asymptomatic neonates (33), but
recent studies have also shown that P[6]G9 circulates in
hospitalized children without diarrhea (34). These strains
are considered naturally attenuated and have been used to
develop a vaccine candidate. Worldwide, rotavirus strains
with the P[6] genotype have been seen in children with
diarrhea (35–37). In Brazil, other studies isolated the P[6]
type from children with acute diarrhea (26–28). In our sur-
vey, several mixed G and P types also appeared but in a
low percentage (2.6%). The detection of unusual strains
and mixed infections in this study suggests a previously
unrecognized diversity among Brazilian rotavirus infec-
tions (28).
Among the single G9 strains detected in this survey,
VP4 genotyping showed that P[8]G9 was the most preva-
lent (75.7%), followed by P[4]G9 (5.4%) and P[6]G9
(1.4%) (data not shown). This diversity among G9 types
has also been detected in other studies (5,6,26). Combined
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Figure 2. Temporal distribution of rotavirus strains from children,
adults, and elderly patients with acute diarrhea, São Paulo, Brazil,
1996–2003.
Figure 3. Rotavirus infection among children (<5 years of age),
school-age children (5–17 years), adults (18–59 years), and elder-
ly patients (>60 years) with acute diarrhea, São Paulo, Brazil,
1996–2003.data from P and G typing are relevant to identify new
strains that might have resulted from reassortment of genes
between diverse human-human and human-animal
rotaviruses (38).
Recently, 2 live rotavirus oral vaccines have been
licensed in some countries and made available on the mar-
ket, including a monovalent vaccine derived from the most
common human rotavirus strain, P[8]G1, and a pentava-
lent vaccine based on a bovine strain, WC3, that contains
5 human-bovine reassortant viruses (G1, G2, G3, G4, and
P[8]). Both vaccines have shown efficacy against severe
rotavirus disease (39,40). In August 2005, the live, attenu-
ated P[8]G1 human rotavirus vaccine was licensed in
Brazil, the first country to introduce this vaccine into the
public health network.
Our data show that challenges exist for the design of
rotavirus vaccine for the Brazilian population and under-
score that virus strain surveillance should be ongoing.
Surveillance programs can establish whether G9 rotavirus
strains will continue to rise in prevalence or whether they
will follow a cyclical pattern of emergence, as has been
shown for G1–G4. The composition of future rotavirus
vaccines is likely to be formulated according to the geo-
graphic setting and the distribution of G and P strains.
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